Should we consider CV risk in treating hypertension?
Metadata[+] Show full item record
This meta-analysis of 11 studies (N=51,917) examined whether the benefits of treating hypertension are proportional to baseline cardiovascular risk. Included were large randomized trials carried out since 1995 that allocated patients to either an antihypertensive agent or placebo, or to a more intensive or less intensive blood pressure regimen.
Evidence-based practice 18, no. 04 (2015): 5